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Summary
The age-related impairment in muscle function results in a drastic decline in motor
coordination and mobility in elderly individuals. Regular physical activity is the only
efficient intervention to prevent and treat this age-associated degeneration. How-
ever, the mechanisms that underlie the therapeutic effect of exercise in this context
remain unclear. We assessed whether endurance exercise training in old age is suffi-
cient to affect muscle and motor function. Moreover, as muscle peroxisome prolifer-
ator-activated receptor c coactivator 1a (PGC-1a) is a key regulatory hub in
endurance exercise adaptation with decreased expression in old muscle, we studied
the involvement of PGC-1a in the therapeutic effect of exercise in aging. Intrigu-
ingly, PGC-1a muscle-specific knockout and overexpression, respectively, precipi-
tated and alleviated specific aspects of aging-related deterioration of muscle
function in old mice, while other muscle dysfunctions remained unchanged upon
PGC-1a modulation. Surprisingly, we discovered that muscle PGC-1a was not only
involved in improving muscle endurance and mitochondrial remodeling, but also
phenocopied endurance exercise training in advanced age by contributing to main-
taining balance and motor coordination in old animals. Our data therefore suggest
that the benefits of exercise, even when performed at old age, extend beyond
skeletal muscle and are at least in part mediated by PGC-1a.
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1 | INTRODUCTION
Aging is a progressive and inevitable biological process leading to a
decay and dysfunction of organs. Skeletal muscle tissue is promi-
nently affected by this decline, as characterized by a loss of strength
and mass starting in the 4th decade in humans, a process known as
sarcopenia (Nair, 2005). Age-related loss of muscle function is fur-
ther exacerbated by reduced balance and motor coordination result-
ing in avoidance of physical ability, increased frailty, elevated
number of falls, and thus bone fractures (Lord, Clark, & Webster,
1991), highly predictive for hospitalization and morbidity (Rolland
et al., 2008). Decreased mobility is associated with an impaired abil-
ity to perform daily tasks or engage in social interactions and thus
markedly affects quality of life (Landi et al., 2017). In addition,
Abbreviations: ATP6, ATP synthase 6; COX1, cytochrome C oxidase I; ND1, NADH
dehydrogenase subunit 1; OXPHOS, oxidative phosphorylation; PGC-1a, peroxisome
proliferator-activated receptor c coactivator 1a; TA, tibialis anterior; TBP, TATA binding
protein.
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muscle dysfunction is associated with many age-associated metabolic
disorders such as insulin resistance, type 2 diabetes, or hypertension,
thereby increasing the risk of cardiovascular death (Nair, 2005).
While multiple events are involved in muscle aging (Marcell, 2003),
mitochondrial dysfunction has been strongly linked to sarcopenia
(Short et al., 2005).
Exercise is the most efficient intervention to improve muscle
function and whole-body metabolism (Egan & Zierath, 2013), while
physical inactivity increases the risk for many chronic diseases asso-
ciated with aging (Booth, Roberts, & Laye, 2012). Endurance exercise
training accordingly helps to ameliorate age-related skeletal muscle
dysfunctions (Cartee, Hepple, Bamman, & Zierath, 2016), not only
limited to the preservation of muscle mass and strength, but also
balance, motor coordination and mobility (Garatachea et al., 2015).
Furthermore, exercise also reduces the age-related decline in insulin
sensitivity (Cartee et al., 2016). Finally, physical activity maintains
normal mitochondrial function in older adults (Gouspillou et al.,
2014). Mitochondrial activity and other exercise-induced phenotypic
changes of skeletal muscle are controlled by the peroxisome prolifer-
ator-activated receptor c coactivator 1a (PGC-1a). For example,
PGC-1a is a master regulator of mitochondrial biogenesis (Schreiber
et al., 2004; Wu et al., 1999), mitochondrial function (Wu et al.,
1999), mitochondrial dynamics (Cannavino et al., 2015), fatty acid
oxidation (Hoeks et al., 2012), and anti-oxidative processes (St-Pierre
et al., 2006). Interestingly, PGC-1a levels are increased by exercise
in muscle (Safdar et al., 2011) and PGC-1a is considered to be a key
player in mitochondrial changes induced by exercise (Safdar et al.,
2011; Ventura-Clapier, Mettauer, & Bigard, 2007). In addition, PGC-
1a extends health span and life span of a mouse model of premature
aging arising from mitochondria defects (Sahin et al., 2011). Impor-
tantly, in line with the mitochondrial decline, PGC-1a expression
decreases during muscle aging in different species, including humans
(Ghosh et al., 2011; Kang, Chung, Diffee, & Ji, 2013; Short et al.,
2005; Vina et al., 2009). Moreover, PGC-1a improves various muscle
disorders, for example, denervation-induced fiber atrophy (Sandri
et al., 2006) or Duchenne muscular dystrophy (Handschin, Kobayashi
et al., 2007). Of note, conclusions about the function of PGC-1a in
the context of natural aging are difficult to extrapolate from prema-
ture aging models, for example, those with severe mitochondrial
impairment. Moreover, other studies reported unchanged muscle
PGC-1a levels despite muscle atrophy in active humans (Gouspillou
et al., 2014). Therefore, the role of PGC-1a in muscle aging remains
an open question and needs to be addressed.
In this work, we investigated the impact of endurance exercise
training at old age on muscle function, age-related motor dysfunc-
tion, and whole-body metabolism in 2-year-old mice. Moreover, we
assessed how muscle-specific gain of function and loss of function
of PGC-1a affects the aging process in sedentary and trained ani-
mals. Previous studies (Kim, Kim, Oh, Kim, & Song, 2013; LeBrasseur
et al., 2009) and current investigations performed in our laboratory
with young animals showed that 3 months of treadmill endurance
training was sufficient to induce significant adaptations in mice. The
age of 21 months as starting point was chosen based on the
presarcopenic state of mice at that age, and to avoid a potential
reduction in lifespan of the PGC-1a knockout mice. While a number
of effects of muscle-specific gene ablation of PGC-1a on muscle
metabolism in aging have been demonstrated (Sczelecki et al., 2014),
we now observed that reduced and elevated PGC-1a levels acceler-
ate and delay, respectively, broader aspects of muscle aging. Inter-
estingly however, we also show that PGC-1a modulation is not
sufficient to fully control muscle aging as some age-related muscle
dysfunctions are not altered by deletion or overexpression of this
coactivator. Moreover, we found that PGC-1a slightly improves
whole-body metabolism and that many beneficial effects of exercise
on mitochondria and muscle function are potentiated by and depen-
dent on this transcriptional coactivator. Finally, we discovered that
the effects of exercise and muscle PGC-1a extend beyond skeletal
muscle tissue, for example, by impacting on motor coordination and
balance.
2 | RESULTS
2.1 | Exercise-associated mitochondrial
improvement in old muscle is dependent on muscle
PGC-1a
Mitochondrial number and function are boosted by endurance
training, while inversely, reduced mitochondrial activity has been
associated with muscle aging. We therefore investigated the impact
of exercise and modulation of muscle PGC-1a expression in old
skeletal muscle in vivo. Even when only performed at advanced
age, endurance exercise training induced PGC-1a expression in the
gastrocnemius and tibialis anterior (TA) muscle of wild-type (WT)
animals (Figure 1a). Surprisingly however, the genotype effect of
overexpression and knockout of PGC-1a on mitochondrial gene
expression was not replicated by exercise (Figure 1b). Nevertheless,
oxidative phosphorylation (OXPHOS) protein levels were elevated
by PGC-1a and exercise (Figure 1c). Importantly, the exercise-
controlled increase in OXPHOS proteins was blunted in the
muscle-specific PGC-1a knockout (mKO) animals. Even though
mitochondrial gene expression and protein levels were already sub-
stantially boosted in muscle-specific PGC-1a transgenic (mTg) mice
beyond the levels that were achieved by endurance exercise in WT
animals, an additional training effect was nevertheless observed in
the mTg model in regard to mitochondrial DNA copy numbers
(Figure 1d).
2.2 | Muscle PGC-1a affects endurance capacity of
untrained and trained skeletal muscle in old mice
Mitochondrial function has been linked to endurance performance in
skeletal muscle. Based on the observed modulation of mitochondrial
properties by exercise and muscle PGC-1a, we next studied the
impact of the corresponding interventions on muscle endurance dur-
ing aging. In all three genotypes, endurance exercise training
improved endurance performance of old mice, even though at lower
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and higher levels in mKO and mTg animals, respectively (Figure 2a).
Similarly, circulating lactate was affected in a genotype-dependent
manner (Figure 2b). Surprisingly, an additional lactate-lowering effect
of endurance exercise training was only observed in mKO and mTg,
but not WT mice. In line with the literature, gene expression regulat-
ing lactate metabolism and glycolysis was affected in both geno-
types, even though these data fail to fully explain the exercise effect
on circulating lactate in the mKOs (Figure 2c and Fig. S1). At least in
the mTg mice with a reported higher number of oxidative muscle
fibers (Handschin, Choi et al., 2007; Lin et al., 2002), this reduction
could be based on the exercise-linked potentiation of the proportion
of type IIa and type I muscle fibers, which was not recorded in WT
or mKO animals (Figure 2d).
2.3 | Aging, exercise and muscle PGC-1a modulate
muscle mass and metabolic parameters
Interestingly, PGC-1a overexpression blunts the age-related decrease
in endurance capacity similarly to exercise, while deletion of the tran-
scription factor did not affect this drop. Besides reduced muscle func-
tion, a loss of muscle force and mass are the key hallmarks of
sarcopenia. An assessment of grip strength accordingly revealed an
age-dependent diminution in maximal grip strength and four limbs
hanging time in all genotypes (Figure 3a,b), correlating with loss of
relative mass of individual muscles (Figure 3d). The differential
increase in body weight in the different genotypes (Fig. S2a) suggests
that those changes might be at least in part driven by an increased
F IGURE 1 PGC-1a levels determine exercise-related mitochondrial improvements (a) Relative PGC-1a gene expression in different muscles
(n = 3–6). (b) Relative gastrocnemius mRNA levels of mitochondrial genes (n = 6). (c) Quadriceps mitochondrial OXPHOS protein levels (n = 6).
(d) Mitochondrial mass quantified in gastrocnemius muscle (n = 6). Values are mean  SEM. *p < .05; **p < .01; ****p < .0001 indicate
statistically significant differences between sedentary and exercised animals of the same genotype, #p < .01; ##p < .01; ###p < .01; ####p < .001
indicate statistically significant differences between genotypes for sedentary and exercised animals
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body mass. However, the absence of changes in absolute muscle
mass, overall lean mass or fiber size in WT animals (Fig. S2b and
Figure 3c–e), suggests that these mice are only at the stage of very
early onset of muscle aging. Strikingly, old mice deficient for muscle
PGC-1a presented an accelerated age-related reduction in four limbs
hanging time, in addition to diminished maximal grip strength, lean
mass, muscle weights, and fiber size compared to WT animals, high-
lighting the development of premature signs of muscle aging in those
mice that might also be in part mediated by an increased body weight
(Fig. S2a). Although mTg animals exhibited a slight age-related loss of
lean mass, it was not significantly different from WT animals and the
impact of PGC-1a overexpression on individual muscle weight reduc-
tion was muscle bed-specific. Even though endurance exercise train-
ing is not the most efficient intervention to improve muscle mass,
exercise partially rescued the loss of maximal grip strength, lean mass,
and muscle weight in old mKO mice, although these parameters
remained lower compared to those in the trained and untrained WT
group (Figure 4a,b,d). Interestingly, exercise improved four limbs
hanging time in old WT mice, but not in mice lacking muscle PGC-1a,
possibly because of their reduced maximal grip strength and muscle
mass (Figure 4b). Surprisingly, this absence of an exercise effect on
mass was also found in mice overexpressing PGC-1a. Nevertheless,
PGC-1a overexpression potentiated the effect of exercise on maxi-
mal grip strength in old animals (Figure 4a).
Muscle mass and function are important predictors of metabolic
homeostasis. Accordingly, the age-associated decrease in muscle
mass and function was linked to a deterioration of glucose tolerance
in WT and mTg animals, whereas young mKO mice already exhibited
a glucose tolerance similar to that of 2-year-old animals (Fig. S3a).
The higher baseline blood glucose levels of young compared to old
mTg animals are the main drivers of the age-related increased AUC in
this genotype. Further analysis showed that down- and up-regulation
of PGC-1a both lowered diastolic blood pressure. However, more
importantly, blood pressure increased in old WT and mKO, but not in
mTg mice (Fig. S3b). Exercise elicited a trend toward reversing age-
associated glucose intolerance in the WT group and failed to signifi-
cantly improve glucose clearance in mTg animals, whereas it did not
lead to any changes in mKO mice (Fig. S4a). Diastolic blood pressure
was not influenced by exercise in any of the genotypes (Fig. S4b).
2.4 | Exercise and PGC-1a improve age-related
impairments in motor coordination and balance
The detrimental effects of sarcopenia in elderly individuals are com-
pounded by a loss of motor coordination and balance. We thus
recorded how motor coordination and balance in old mice can be
modulated by exercise and muscle PGC-1a using balance beam- and
Rotarod-based tests. The number of foot slips and the time needed
to cross the balance beam rise dramatically with increasing age in all
three genotypes (Figure 5a). Strikingly however, the mKO mice
exhibited the phenotype of 24-month-old WT mice already at the
age of 12 months. Inversely, the age-dependent reduction in both
motor coordination and balance performance was blunted in mTg
animals. Curiously, young mKO and mTg mice performed better in
Rotarod tests at young age (Figure 5b). Again, a more precipitous
drop in performance was observed in mKO animals at 12 months of
age. Further analysis identified disparate age-related modulations of
neuromuscular junction transcripts across the different genotypes
(Figure 5c), suggesting an alternative reshaping of the neuromuscular
junction according to PGC-1a expression levels. Endurance exercise
training of old animals inversely improved the number of foot slips
and the time to cross the balance beam in mKO mice (Figure 6a).
Moreover, the time to cross the balance beam was also reduced in
trained WT animals to the level observed in sedentary mTg mice.
Similarly, Rotarod performance in WT mice after exercise reached
the level of sedentary mTg animals (Figure 6b). Strikingly, mKO mice
did not respond to exercise in the Rotarod-based assessment of
motor coordination.
3 | DISCUSSION
Exercise is widely accepted as one of the most efficient treatments
against the effects of systemic and muscle-specific aging (Garatachea
et al., 2015; Gremeaux et al., 2012). We show here that even when
performed only at old age, exercise is sufficient to prevent or even
improve many age-related deteriorations. While evidence has been
presented that demonstrate a role for PGC-1a modulation in the
muscle metabolism and inflammation of old muscle-specific knockout
animals (Sczelecki et al., 2014), we now have studied the role of this
coactivator in muscle aging in the context of exercise as well as both
gain of function and loss of function. Most surprisingly, we observed
a strong involvement of muscle PGC-1a in the control of motor
coordination and balance. An improvement of these parameters has
been shown in exercise, which exerts pleiotropic effects on different
organs and cell types. Our findings now demonstrate that muscle-
intrinsic changes triggered by PGC-1a are sufficient to affect motor
coordination and balance in old mice. Prior work revealed that cen-
tral nervous system-specific expression of PGC-1a is essential for
motor function (Lucas et al., 2012; Zhao et al., 2011). Our present
F IGURE 2 PGC-1a potentiates exercise-dependent endurance increase (a) Endurance level of mice challenged on a treadmill (n = 8–10). (b)
Pre and postexercise blood lactate levels (n = 8–10). (c) Relative quadriceps mRNA levels of genes involved in lactate regulation and glycolysis
(n = 4–6). (d) Representative pictures and quantification of fiber type staining of tibialis anterior muscles (red = type 1 fibers and cell
membranes; blue = type 2A fibers; green = type 2B fibers; black = type 2X fibers). Scale bars represent 100 lm (n = 4–6). Values are
mean  SEM. *p < .05; **p < .01; ***p < .001; indicate statistically significant differences between sedentary and exercised animals of the
same genotype, #p < .01; ##p < .01; ###p < .01; ####p < .001 indicate statistically significant differences between genotypes for sedentary and
exercised animals, @@p < 0.01; @@@@p < 0.0001 indicate statistically significant differences pre- and post-exhaustion
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data would suggest that skeletal muscle possibly initiates a retro-
grade signaling to the nervous system with a similar outcome, but
further studies would be needed to test this hypothesis. Analogous
findings have been reported in the remodeling of the neuromuscular
junction (Arnold et al., 2014). Several muscle-intrinsic and muscle-
extrinsic factors contribute to maintenance of motor coordination
and balance besides neuronal changes, including motor planning,
strength, and endurance, all of which are decreased with age
F IGURE 3 Absence of PGC-1a accelerate sarcopenia (a) Maximal grip strength (n = 10–12). (b) Four limbs hanging time (n = 10–12). (c)
Lean relative to body mass (n = 10). (d) Muscle mass relative to body weight (n = 5–6). (e) Tibialis anterior fiber type specific minimum ferret
diameter (n = 3–4). Values are mean  SEM. *p < .05; **p < .01; ***p < .001; ****p < .0001 indicate statistically significant differences
between young and old animals of the same genotype. #p < .01; ##p < .01; ####p < 0.001 indicate statistically significant differences between
genotypes of age-matched animals
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(Garatachea et al., 2015). Thus, reduced muscle mass in aged mKO-
PGC-1a mice compared to age-matched WT animals and the ensuing
reduction in maximal grip strength could be important for balance
and motor coordination (Schultz, Ashton-Miller, & Alexander, 1997).
Additionally, muscle fiber contraction speed is essential to counter-
act disequilibrium or to initiate adaptations to changes in motor
planning (Schultz et al., 1997). This parameter is highly dependent
on calcium homeostasis (Berchtold, Brinkmeier, & Muntener, 2000).
Interestingly, muscle PGC-1a remodels sarcoplasmic reticulum cal-
cium handling (Summermatter et al., 2012) and thereby possibly
affects muscle contraction and ultimately locomotor function. Fur-
thermore, neuromuscular junctions, which constitute the interface
allowing a proper communication between motor neurons and mus-
cles, are severely deteriorated during aging (Tintignac, Brenner, &
Ruegg, 2015). This impairment causes inappropriate or inefficient
muscle contraction, as well as the defect of retrograde signaling from
the muscle to the nerves, thereby dramatically impacting muscle
force, motor coordination, and balance. Interestingly, muscle PGC-1a
overexpression ameliorates neuromuscular junction morphology and
function, which might also contribute to the improvement of age-
related motor dysfunction (Arnold et al., 2014). Likewise, the modu-
lation of expression of several neuromuscular junction genes found
in this study implies an age- and genotype-dependent remodeling of
this structure that could affect the motor function of our animals
during aging. However, a more careful and comprehensive analysis
of the morphology and function of the neuromuscular junction will
have to be performed to reach conclusions about a potential protec-
tive effect of PGC-1a against neuromuscular junction degeneration
in old muscle. Of note, ablation of muscle PGC-1a abolished the
effect of exercise on motor coordination and bunted the exercise-
associated increase in endurance. Conversely, overexpression of
muscle PGC-1a boosted the effect of exercise on both muscle
endurance and maximal grip strength. Those data indicate that the
exercise effects on motor coordination, endurance, and maximal grip
strength, at least as assessed in our tests, are modulated upon alter-
ation of muscle PGC-1a levels. Interestingly however, the beneficial
effect of PGC-1a on age-related and exercise-mediated muscle
adaptations is limited to specific alteration of muscle functions and
F IGURE 4 Exercise reduces premature sarcopenia in the absence of PGC-1a (a) Maximal gip strength (n = 8–10). (b) Four limbs hanging
time (n = 8–10). (c) Lean relative to body mass (n = 8–10). (d) muscle mass relative to body weight (n = 5–6). Values are mean  SEM.
*p < .05; **p < .01; indicate statistically significant differences between sedentary and exercised animals of the same genotype, # p < .01;
##p < .01; ####p < .001 indicate statistically significant differences between genotypes for sedentary and exercised animals
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F IGURE 5 PGC-1a delays locomotor dysfunction during aging (a) Balance performances measured during balance beam crossing (n =
10–12). (b) Motor coordination of mice challenged with a Rotarod (n = 10–12). (c) Relative mRNA levels of neuromuscular junction genes
measured in tibialis anterior muscles (n = 5–6). Values are mean  SEM. *p < .05; **p < .01; ***p < .001; ****p < .0001 indicate statistically
significant differences between young and old animals of the same genotype. #p < .01; ##p < .01; ###p < .01; ####p < .001 indicate statistically
significant differences between genotypes of age-matched animals
F IGURE 6 PGC-1a elevation mimic exercise to improve locomotor function in aged mice (a) Balance performances measured during
balance beam crossing (n = 8–10). (b) Motor coordination of mice challenged with a Rotarod (n = 10). Values are mean  SEM. *p < .05;
**p < .01; indicate statistically significant differences between sedentary and exercised animals of the same genotype. #p < .01; ###p < .01;
indicate statistically significant differences between genotypes for sedentary and exercised animals
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thus is insufficient to control the entire biological program. For
example, while PGC-1a deletion abrogated the exercise-related
increase in Rotarod performance, improvements in balance induced
by exercise were unaffected in these mice. Similarly, opposite to four
limbs hanging time, the boosts in muscle mass and maximal grip
strength postexercise are not prevented by the absence of PGC-1a
indicating that other elements can compensate for the genetic abla-
tion of this gene. Finally, while overexpression of PGC-1a strikingly
ameliorated motor and muscle functions, no change in maximal grip
strength and mass was observed. These data show that PGC-1a
plays a complex and nuanced role in muscle aging as genetic ablation
and transgenic overexpression affect very specific aspects of muscle
biology in old mice.
In our experimental paradigm, exercise did not affect whole-body
muscle mass and only quadriceps muscle mass in our WT animals. In
line with these results, maximal grip strength was likewise unaf-
fected. Resistance exercise would probably be more effective in
improving these parameters. Nevertheless, endurance exercise train-
ing increased four limbs hanging time and running capacity in WT
mice. Endurance exercise might thus be sufficient to improve sar-
copenia at a later age and upon higher muscle strength loss. This is
supported by the partial restoration of both muscle mass and maxi-
mal grip strength in mKO mice, which displayed an advanced stage
in sarcopenia.
Interestingly, even though exercise improved PGC-1a muscle
gene expression in some muscles, no changes in mRNA levels of
mitochondrial genes were observed. In contrast, an elevation in
OXPHOS protein levels correlated with the increased endurance
performance of these mice, similar to what has been described in
young compared to old humans (Robinson et al., 2017). Strikingly,
PGC-1a muscle deletion blunted exercise induction of OXPHOS
proteins and PGC-1a overexpression potentiated the effects of
exercise on mitochondrial mass and on the proportion of oxidative
fibers. Considering the impact of age on both type I and II muscle
fibers (Purves-Smith, Sgarioto, & Hepple, 2014) and the proportion
of 50% of type I fibers in human limb muscle, an analysis of the
role of PGC-1a in the protection of type I fiber in mouse soleus
muscle will be of interest. Nevertheless, our data demonstrate that
exercise improves mitochondrial fitness and oxidative metabolism in
a PGC-1a-dependent manner, also in old muscles. Correlating with
our results, previous work showed that global and muscle-specific
PGC-1a deletion prevents exercise-associated amelioration of mito-
chondria (Leick, Lyngby, Wojtaszewski, & Pilegaard, 2010). Of note,
the mitochondrial number in WT and mKO animals, at least as sug-
gested by the quantification of mitochondrial DNA, did not reflect
the close link between mitochondria and endurance capacity
(Figure 1d). This suggests that increased OXPHOS protein levels per
individual mitochondria could contribute to the improved exercise
performance.
Skeletal muscle is the largest tissue responding to insulin and
therefore is a primary site for whole-body glucose uptake, utilization,
and storage. Glucose intolerance and increased blood pressure repre-
sent hallmarks of the age-related metabolic syndrome (Hildrum,
Mykletun, Hole, Midthjell, & Dahl, 2007). In line with the aggravated
glucose intolerance in old mKO animals described previously (Scz-
elecki et al., 2014), we observed that absence of muscle PGC-1a
accelerated glucose intolerance during aging. Even though no overt
amelioration in glucose tolerance was observed in the mTG mice,
overexpression of muscle PGC-1a abolished the age-associated
increase in blood pressure. Therefore, collectively, muscle PGC-1a
reduces the development of an age-related metabolic syndrome. As
the metabolic syndrome is highly predictive for heart disorders and
failure (Perrone-Filardi et al., 2015), it would be interesting to study
the effect of exercise combined with modulation of muscle PGC-1a
on the aging heart.
In conclusion, our findings demonstrate that many of the benefi-
cial effects of exercise involve the action of muscle PGC-1a. Of
note, some parameters show an additive effect of endurance exer-
cise with overexpression of PGC-1a, suggesting an obvious thera-
peutic relevance. While an improvement of motor coordination and
balance could have been expected from the exercise intervention,
the striking effect of overexpression and ablation of muscle PGC-1a
reveal a hitherto unsuspected contribution of muscle fibers to these
neuronally controlled processes. More work is required to identify
the molecular mechanisms that underlie this observation. Neverthe-
less, our data highlight the importance of proper muscle function on
aging-related deteriorations that transcend the immediate effects on
muscle fibers.
4 | MATERIAL AND METHODS
4.1 | Animals
Mice with muscle ablation (mKO) and overexpression (mTg) of
PGC-1a were described previously (Handschin, Choi et al., 2007;
Lin et al., 2002). C57/Bl6 wild-type (WT) mice were obtained from
Janvier (Janvier sas, cs 4105, le genest St-isle f-53941, St Berthe-
vin Cedex). Animals were fed ad libitum with regular chow diet
(Provimi 3432) and kept under a 12-h/12-h light–dark cycle
(06:00 to 18:00) at 23°C. Studies were performed with 3-, 12-,
and 24-month-old male mice (3, 12, and 24 months). At
21 months, groups of mice were trained on a treadmill during
12 weeks, 3 times per week, for 30 min. Maximal speed was
determined prior to the beginning of the endurance exercise train-
ing by an exhaustion test. The exercise protocol started at 50%
of maximal speed in the first week and was gradually increased
each week to reach 80%. All experiments were performed in
accordance with the federal guidelines for animal experimentation
and were approved by the Kantonales Veterin€aramt of the Kanton
Basel-Stadt.
4.2 | Mice phenotyping
For all behavioral experiments, mice were acclimatized to the room
for 1 hr prior to the tests and experimenters were blinded for the
animal genotype and the treatment wherever possible.
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4.2.1 | Balance performance
Mice were placed on one side of an inclined 6-mm-diameter beam
and were motivated to walk across the bar toward a red house used
as a positive stimulus. A lamp was placed at the starting point as an
adverse stimulus. Mice were acclimatized to the apparatus for one
day with 3 beam crossing including 15 s of rest in the red house
between trials. Time required to cross the beam and number of foot
slips made during the crossing were recorded during the 3 following
days with 3 trials per day.
4.2.2 | Motor coordination and planning
Mice were placed on a horizontally oriented, rotating cylinder (rod).
For 3 consecutive days, mice were acclimatized 3 9 1 min per day
on the Rotarod instrument set to rotate at 5 rpm. On the 5 follow-
ing days, mice were tested with accelerating speed (5–68 rpm in
7 min with directional reversal). Mice were tested three times in a
row with 10 min of rest between each trial. The time the mice
spend on the rod before falling was recorded and averaged over the
5 days.
4.2.3 | Maximal grip strength and four limbs
hanging time
Maximal grip strength was recorded using a grip strength meter
(Chatillon). Five measurements were performed with 1-min recovery
periods between the repetitions. The maximum value obtained was
used for the analysis. Four limbs hanging time was measured by
placing mice on an elevated inverted grid and measuring the
maximum time until the mice released and fell.
4.2.4 | Endurance exercise capacity
Mice were acclimatized to treadmill running (Columbus Instru-
ments) for 2 days. Acclimatization was performed with an inclina-
tion of 5% at a speed of 8 m/min for 5 min followed by 5 min
of 10 m/min. The exhaustion test was performed one day after
acclimatization, starting at a speed of 4.8 m/min and a subse-
quent an increased by 1.6 m/min every 3 min until a speed of
29 m/min was reached. When mice reached exhaustion, the max-
imal running distance was recorded. Blood was drawn from the
tail vein before and 10 min after the test, and blood lactate
levels were measured with a lactate plus meter (Nova biomedi-
cal).
4.3 | Metabolism measurements
4.3.1 | Body composition
Body composition was assessed with an EchoMRI-100 analyzer
(EchoMRI Medical Systems). Fat and lean mass were adjusted to
body weight.
4.3.2 | Glucose homeostasis
All mice were acclimatized to handling before the experiment. Mice
were fasted for 16-hr overnight before intraperitoneal injection of a
bolus of 2 g (glucose)/kg (body weight). Blood glucose levels were
recorded from the tail vein with a glucose meter (Accu-Chek, Roche
Diagnostics) at 0, 15, 30, 45, 60, 90, and 120 min after glucose
injection. The AUC was calculated as described (Heikkinen, Argmann,
Champy, & Auwerx, 2007).
4.3.3 | Blood pressure
Blood pressure was measured with a tail cuff BP-2000 Blood Pres-
sure Analysis System (Visitech Systems) on 5 consecutive days. Five
premeasurements and 15 measurements were performed in a row.
The average values of the 15 measurements over the 5 days were
used for analysis.
4.4 | Mouse muscle preparation
Body weight of the mice was measured before sacrifice by CO2
inhalation. Muscles were directly collected and weighed before being
either snap-frozen in liquid nitrogen for protein and RNA extraction,
embedded in 7% tragacanth using cooled-isopentane for cryosection
staining.
4.5 | Mitochondria DNA copy number and gene
expression
4.5.1 | Genomic DNA
Powdered muscles were incubated overnight at 55° in lysis buffer
(10 mM Tris-HCl, 1 mM EDTA, 0.1% SDS 5% Proteinase). After a 15-
min centrifugation step at 8,000 g, residual RNA of the re-suspended
lysate was removed with a RNase A treatment (20 mg/ml) during
30 min at 37°C. RNase A was heat-inactivated at 95°C for 30 min.
Samples were mixed with one volume of phenol/chloroform/isoamyl
alcohol (25:24:1) and centrifuged at 8,000 g for 15 min. The aque-
ous phase was transferred to a fresh tube, and one volume of chlo-
roform was added. After an identical centrifugation step, one volume
of isopropanol containing 0.3M of sodium acetate was added. Sam-
ples were then kept at 20°C for 30 min. A centrifugation step was
repeated at 4°C. DNA pellets were washed 2 times with 1 ml of ice-
cold 75% ethanol and finally recovered in ddH2O. 0.1 lg of gDNA
was analyzed by qPCR to measure mitochondrial DNA copy
numbers.
4.5.2 | RNA extraction and qPCR
Lysing matrix tubes (MP Biomedicals 6913-500) and TRI Reagent
(Sigma-Aldrich T9424) were used to isolate RNA from crushed mus-
cle. NanoDrop 1000 spectrophotometer (Thermo Scientific) was
used to measure RNA concentration and purity to ensure that the
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ratios of 260/280 and 260/230 were above 1.8. An Agilent Bioana-
lyzer (Agilent 2100 Bioanalyzer, Agilent Technologies) determined
the level of RNA degradation. DNA was removed with RNase-free
DNase (Invitrogen 18068-015), and one microgram of RNA was used
for reverse transcription using SuperScript II reverse transcriptase
(Invitrogen 18064-014).
Relative DNA copy number or mRNA levels were determined
using a Light Cycler 480 system (Roche Diagnostics) with FastStart
Essential DNA probe master mix (Roche Diagnostics 06402682001).
Relative mRNA quantification was performed with the DDCT method
using the TATA binding protein (TBP) gene as reference. Mitochon-
drial DNA copy number was evaluated by normalizing the average of
COX1 ATP6 and ND1DNA copy number with the average copy
number of the nuclear genes beta globin and 34B6. Beta globin,
34B6, and TBP levels were similar in all samples. Primer used is
listed in Table S1.
4.6 | Immunostaining
Eight-lm muscle cryosections were cut with a cryostat (Leica,
CM1950). Sections were blocked for 30 min at ambient temperature
in PBS containing 0.4% Triton X-100 and 10% goat serum. Fiber
types and cell membranes were labeled with primary and secondary
antibodies for one hour at room temperature in PBS with 10% goat
serum (antibody dilutions and information are described in Table S2).
Incubation with secondary antibodies was performed in the dark. All
secondary antibodies were from Life technologies. Three washes of
5 min in PBS were performed before and after antibody incubation.
Nuclei were stained using ProLong Gold Antifade mounting medium
with Dapi (Life Technologies, P36931). Images were taken using the
FEI MORE microscope with a 209 magnification lens keeping the
same acquisition settings for all compared samples. Fiber type per-
centages and diameters were quantified in whole muscle sections
using the ImageJ and cell^P software (Olympus Soft Imaging Solu-
tion) with unaltered images. Representative images were, however,
adjusted for brightness and contrast for visualization purposes.
4.7 | Protein levels
Total protein was recovered from quadriceps muscles as described in
Perez-Schindler, Summermatter, Santos, Zorzato, and Handschin
(2013). Equal amounts of protein were migrated on mini-TGX 4-20%
stain free precast gel (Bio-Rad, 4568096) and labeled with the in-gel
trihalo compounds under UV for 1 min. Gel and nitrocellulose mem-
branes were allowed to equilibrate for 5 min in transfer buffer. Pro-
tein transfer was performed at a constant voltage of 100 V for 1 hr.
Membranes were blocked for 1 hr at room temperature with 5%
BSA diluted in TBS-T and washed 29 for 5 min with TBS-T. Mem-
branes were then incubated overnight at 4°C with primary antibod-
ies (Abcam, ab110413, 1/1000) diluted in TBS-T containing 0.02%
sodium azide and 3% BSA. Membranes were washed 39 for 5 min
with TBS-T and incubated 1 hr at room temperature with
peroxidase-conjugated secondary antibodies (Dako, P0260, 1/10000)
diluted in TBS-T plus 3% BSA. The same washing step was repeated
before antibody binding was revealed using an enhanced chemilumi-
nescence HRP substrate detection kit (Thermo Scientific, 34076) and
imaged using a Fusion FX imager. Total protein content was deter-
mined using the trihalo compounds labeling. Two reference samples
were loaded in the different gels for intergel normalization. Proteins’
quantification was performed using the Fusion FX software.
4.8 | Statistical analysis
Data were analyzed with two-way ANOVA (GraphPad Prism soft-
ware). Sidak posttests were used to do multiple comparison analysis
following two-way ANOVA. All data are plotted as mean  SEM.
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Table S1: qPCR primer sequences 
Gene name forward sequence reverse sequence 
βglobin GAAGCGATTCTAGGGAGCAG GGAGCAGCGATTCTGAGTAGA 
36B4 ACTGGTCTAGGACCCGAGAAG TCAATGGTGCCTCTGGAGATT 
ATP6 AGTATGAGCTGGAGCCGTAATTACA TGGAAGGAAGTGGGCAAGTG 
COX1 TGCTAGCCGCAGGCATTACT GCGGGATCAAAGAAAGTTGTG 
COX5a CGCCGCTGTCTGTTCCAT AAACTCCTCATCTGTCTCGTGTGA 
COX5b CTTCAGGCACCAAGGAAGAC TTCACAGATGCAGCCCACTA 
ERRα CGGTGTGGCATCCTGTGA CTCCCCTGGATGGTCCTCTT 
ND1 TCTGCCAGCCTGACCCATA GGGCCCGGTTTGTTTCTG 
NRF1 TCCCCCGAGGACACTTCTT ATCAGCTGCCGTGGAGTTG 
PGC-1α AGCCGTGACCACTGACAACGAG GCTGCATGGTTCTGAGTGCTAAG 
SDH GCTGGTGTGGATGTCACTAAGG CCCACCCATGTTGTAATGCA 
TBP ATATAATCCCAAGCGATTTGC GTCCGTGGCTCTCTTATTCTC 
MuSK ATCCCAACCCCATGTACCAG CCTTAAGCATCTTCACGGCC 
AchEst CGGAGGCTCTCATCAATACTGG GGGACCCCGTAAACCAGAAAG 
Rapsyn AGACAGCCTTCCCTCGGTA CTTCAGCTAAGTCCTGGGCT 
Agrn ATGGCAAGACACCCTCACTG TCCTTGCAGTCTCCCCAAAC 
Erbb2 AAGAGGTCACAGCTGAGGAC AAAATGCCAGGCTCCCAAAG 
AChRβ CATCATCGCTCACCCCAC ACGGTCCACAACCATGGC 
AChRε TGTTTGAGGGTCAGAGGCAT AGTTCCTCTCCAGTGGCTTC 
AChRα AGTCCAATAACGCCGCTGAG TTTCCTAGCGATGGCTATGG 
AChRδ ACAAAGTGGATGTCGCCCTA TCTCTGGTAGCCACACCATG 
AChRγ GACCAACCTCATCTCCCTGA GAGAGCCACCTCGAAGACAC 
Utrophin GAGGCTCGCTTCTACATGCT TGATGACACCATCGCCAGAC 
 
  
2 
 
Table S2: Antibody information 
Primary antibodies Secondary antibodies 
Product# Company Labelling Dilution Product# Labelling Dilution
BA-F8 DSHB m IgG b2 MHC type 1  1:25 A-21242  AF647 IgG GaM   1:250 
SC-71  DSHB m IgG1 MHC type 2a   1:200 A-21124  
AF568 IgG1 
GaM  
 1:100 
BF-F3 DSHB m IgM MHC type 2b   1:100 A-21042  AF488 IgM GaM   1:400 
L9393  Sigma r IgM Laminin  1:5000 A-11008  AF488 IgG GaR   1:500 
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Fig. S1 : Exercise‐dependent regulation of glycolysis genes. Relative quadriceps mRNA levels of
genes involved in lactate regulation and glycolysis (n=4‐6). Values are mean ± SEM. *P < 0.05; **P
< 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences between young
and old animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate
statistically significant differences between genotypes of age‐matched animals.
Fig. S2 : Body weight (n=10‐12) (a) and absolute mass of isolated muscles (n=5‐6) (b) Values are
mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant
differences between young and old animals of the same genotype, # p<0.01; ## p<0.01; ###
p<0.01; #### p<0.001 indicate statistically significant differences between genotypes of age‐
matched animals.
ba
ba
Fig. S3 : PGC‐1α improves systemic aging (a) Glucose tolerance test curves and area under the
curves (n=10) (b) Diastolic blood pressure (n=10). Values are mean ± SEM. *P < 0.05; **P < 0.01;
***; P < 0.001; ****p<0.0001 indicate statistically significant differences between young and old
animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate
statistically significant differences between genotypes of age‐matched animals.
Fig. S4 : Exercise and PGC‐1α modulation impacts on systemic aging (a) Glucose tolerance test
curves and area under the curves (n=8‐10) (b) Diastolic blood pressure (n=10‐12) Values are mean
± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant
differences between sedentary and exercised animals of the same genotype, # p<0.01; ## p<0.01;
### p<0.01; #### p<0.001 indicate statistically significant differences between genotypes for
sedentary and exercised animals.
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